The primary goals of this investigation are to determine the extent of language abnormalities in mania and schizophrenia, to map them functionally, and to assess them longitudinally. The investigation proposes to evaluate both language perception and language production. Evaluation of language perception will focus on both syntactical and semantic processing using experimental tasks originally developed in psycholinguistic studies of normal speech. Pragmatic aspects of language will be evaluated by examining language production with three methods: a rating scale developed by the investigator which assesses severity and type of language disorder, linguistic approaches which emphasize reference and cohesion, and a computerized taxonomic approach. Rigorous diagnostic criteria are used for the definition of patient groups, and the full spectrum of psychotic disorders will be studied (i.e., mania, schizoaffective disorder, paranoid schizophrenia, and hebephrenic schizophrenia). Evaluations will be completed longitudinally, with assessment at admission, at discharge, and at two months after discharge.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH031593-06
Application #
3375238
Study Section
(PCBA)
Project Start
1979-01-01
Project End
1987-06-30
Budget Start
1985-01-01
Budget End
1987-06-30
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Rudd, Danielle S; Axelsen, Michael; Epping, Eric A et al. (2014) A genome-wide CNV analysis of schizophrenia reveals a potential role for a multiple-hit model. Am J Med Genet B Neuropsychiatr Genet 165B:619-26
Onwuameze, O E; Nam, K W; Epping, E A et al. (2013) MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychol Med 43:619-31
Andreasen, Nancy C; Liu, Dawei; Ziebell, Steven et al. (2013) Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry 170:609-15
Fusar-Poli, P; Smieskova, R; Kempton, M J et al. (2013) Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev 37:1680-91
Salinas, Joel; Mills, Elizabeth D; Conrad, Amy L et al. (2012) Sex differences in parietal lobe structure and development. Gend Med 9:44-55
Wassink, Thomas H; Epping, Eric A; Rudd, Danielle et al. (2012) Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia. Arch Gen Psychiatry 69:885-92
Andreasen, N C; Wilcox, M A; Ho, B-C et al. (2012) Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. Mol Psychiatry 17:1093-102
Crespo-Facorro, B; Roiz-Santiáñez, R; Pérez-Iglesias, R et al. (2011) Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features. Psychol Med 41:1449-60
Andreasen, Nancy C; Nopoulos, Peg; Magnotta, Vincent et al. (2011) Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry 70:672-9
Ho, Beng-Choon; Wassink, Thomas H; Ziebell, Steven et al. (2011) Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res 128:66-75

Showing the most recent 10 out of 216 publications